Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard B Fox

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Synthesis and SAR of aminoalkoxy-biaryl-4-carboxamides: novel and selective histamine H3 receptor antagonistsRamin Faghih, Wesley Dwight, Jia Bao Pan, et al.
Biochemical Pharmacology|January 12, 2007
Differential effects of ciproxifan and nicotine on impulsivity and attention measures in the 5-choice serial reaction time testMark Day, Jia Bao Pan, Michael J Buckley, et al.
Cancer Chemotherapy and Pharmacology|February 14, 2012
FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft modelSarah R Mudd, Martin J Voorbach, David R Reuter, et al.
Psychopharmacology|November 10, 2006
The drug-induced helplessness test: an animal assay for assessing behavioral despair in response to neuroleptic treatmentMichael E Ballard, Ana M Basso, Kelly B Gallagher, et al.
Brain Research|May 25, 2005
Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugsMin Zhang, Michael E Ballard, Liping Pan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 3, 2005
Antidepressant-like effect of D(2/3) receptor-, but not D(4) receptor-activation in the rat forced swim testAna M Basso, Kelly B Gallagher, Natalie A Bratcher, et al.
Anti-Cancer Drugs|April 29, 2009
ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculatureYanping Luo, Vincent P Hradil, David J Frost, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 9, 2010
Magnetic resonance imaging detection and time course of cerebral microhemorrhages during passive immunotherapy in living amyloid precursor protein transgenic miceFeng Luo, Nathan R Rustay, Terese Seifert, et al.
Journal of Neuroimmunology|April 7, 2009
Distinct spatiotemporal pattern of CNS lesions revealed by USPIO-enhanced MRI in MOG-induced EAE rats implicates the involvement of spino-olivocerebellar pathwaysChih-Liang Chin, Madhavi Pai, Peter F Bousquet, et al.
Cancer Chemotherapy and Pharmacology|November 15, 2011
A novel multi-targeted tyrosine kinase inhibitor, linifanib (ABT-869), produces functional and structural changes in tumor vasculature in an orthotopic rat glioma modelYanping Luo, Fang Jiang, Todd B Cole, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Synthesis and SAR of aminoalkoxy-biaryl-4-carboxamides: novel and selective histamine H3 receptor antagonistsRamin Faghih, Wesley Dwight, Jia Bao Pan, et al.
Biochemical Pharmacology|January 12, 2007
Differential effects of ciproxifan and nicotine on impulsivity and attention measures in the 5-choice serial reaction time testMark Day, Jia Bao Pan, Michael J Buckley, et al.
Cancer Chemotherapy and Pharmacology|February 14, 2012
FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft modelSarah R Mudd, Martin J Voorbach, David R Reuter, et al.
Psychopharmacology|November 10, 2006
The drug-induced helplessness test: an animal assay for assessing behavioral despair in response to neuroleptic treatmentMichael E Ballard, Ana M Basso, Kelly B Gallagher, et al.
Brain Research|May 25, 2005
Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugsMin Zhang, Michael E Ballard, Liping Pan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 3, 2005
Antidepressant-like effect of D(2/3) receptor-, but not D(4) receptor-activation in the rat forced swim testAna M Basso, Kelly B Gallagher, Natalie A Bratcher, et al.
Anti-Cancer Drugs|April 29, 2009
ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculatureYanping Luo, Vincent P Hradil, David J Frost, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 9, 2010
Magnetic resonance imaging detection and time course of cerebral microhemorrhages during passive immunotherapy in living amyloid precursor protein transgenic miceFeng Luo, Nathan R Rustay, Terese Seifert, et al.
Journal of Neuroimmunology|April 7, 2009
Distinct spatiotemporal pattern of CNS lesions revealed by USPIO-enhanced MRI in MOG-induced EAE rats implicates the involvement of spino-olivocerebellar pathwaysChih-Liang Chin, Madhavi Pai, Peter F Bousquet, et al.
Cancer Chemotherapy and Pharmacology|November 15, 2011
A novel multi-targeted tyrosine kinase inhibitor, linifanib (ABT-869), produces functional and structural changes in tumor vasculature in an orthotopic rat glioma modelYanping Luo, Fang Jiang, Todd B Cole, et al.
Pageof 7